Title: Predictive factors for esophageal stenosis in patients receiving prophylactic steroid
therapy after endoscopic submucosal dissection for esophageal squamous cell carcinoma
Version: 1 Date: 20 Oct 2023
Reviewer's report:
1#Results and Table 2 are inconsistent.
2#The results in the abstract are identical to those in the main text. The abstract should highlight
key findings.
3#The use of hormones may be influenced by factors such as lesion size, depth, and treatment
history. Physicians may use these factors to make decisions on prophylactic hormone use.
Consequently, hormone usage may be related to these factors. It's understandable that lesions
that require prophylactic hormone use are generally larger and deeper, or they may have pre-
existing treatment history resulting in submucosal fibrosis. Therefore, the clinical significance
of this study is limited. In summary, this article does not offer significant novelty compared to
previous studies on esophageal stenosis.
Title: Predictive factors for esophageal stenosis in patients receiving prophylactic steroid
therapy after endoscopic submucosal dissection for esophageal squamous cell carcinoma
Version: 1 Date: 20 Oct 2023
Reviewer's report:
1#Results and Table 2 are inconsistent.
2#The results in the abstract are identical to those in the main text. The abstract should highlight
key findings.
3#The use of hormones may be influenced by factors such as lesion size, depth, and treatment
history. Physicians may use these factors to make decisions on prophylactic hormone use.
Consequently, hormone usage may be related to these factors. It's understandable that lesions
that require prophylactic hormone use are generally larger and deeper, or they may have pre-
existing treatment history resulting in submucosal fibrosis. Therefore, the clinical significance
of this study is limited. In summary, this article does not offer significant novelty compared to
previous studies on esophageal stenosis.
Please review this paper.
user
Title: Predictive factors for esophageal stenosis in patients receiving prophylactic steroid
therapy after endoscopic submucosal dissection for esophageal squamous cell carcinoma
Version: 1 Date: 20 Oct 2023
Reviewer's report:
1#Results and Table 2 are inconsistent.
2#The results in the abstract are identical to those in the main text. The abstract should highlight
key findings.
3#The use of hormones may be influenced by factors such as lesion size, depth, and treatment
history. Physicians may use these factors to make decisions on prophylactic hormone use.
Consequently, hormone usage may be related to these factors. It's understandable that lesions
that require prophylactic hormone use are generally larger and deeper, or they may have pre-
existing treatment history resulting in submucosal fibrosis. Therefore, the clinical significance
of this study is limited. In summary, this article does not offer significant novelty compared to
previous studies on esophageal stenosis.
assistant